NCT00002350View on ClinicalTrials.gov

A Phase I Trial of APL 400-003 Vaccine: Safety and Immune Response Evaluations of Multiple Injections at Escalating Doses in Asymptomatic HIV-Infected Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

BIOLOGICAL

APL 400-003

Trial Locations (1)

19104

Univ of Pennsylvania Med Ctr, Philadelphia

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Apollon

INDUSTRY